Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 256 participants.

Also called NCT06697314

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 256 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06697314
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06697314. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-15 (actual); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
Acronym
RECOVER-AV
Condition
Acute Pulmonary Embolism (PE)
Condition
Pulmonary Embolism
Intervention (Device)
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
Lead sponsor
Angiodynamics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06697314
Content hash
774246b366023bfb83dac84f361b44ac6ebab8aa26e28bf78956a2c30953f1f9